sotalol has been researched along with Syncope in 22 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient was under amiodarone and sotalol therapy for atrial fibrillation, with no obvious QT prolongation prior to ciprofloxacin therapy." | 7.75 | Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy. ( Arnaoutoglou, C; Chrisopoulos, C; Keivanidou, A; Kirpizidis, C; Krommydas, A; Papanikolaou, G; Tsiptses, K, 2009) |
| "Thirteen patients developed syncope and a prolonged QTc interval while taking therapeutic doses of sotalol." | 7.67 | Sotalol, hypokalaemia, syncope, and torsade de pointes. ( Barlow, JB; McKibbin, JK; Millar, RN; Obel, IW; Pocock, WA, 1984) |
| "Significant differences between pre- and posttreatment number of VPC, severity of arrhythmia, HR variables, or occurrence of syncope were not observed in dogs treated with atenolol or procainamide." | 5.10 | Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers. ( Atkins, CE; DeFrancesco, TC; Gordon, SG; Hamlin, RL; Keene, BW; Meurs, KM; Miller, MW; Moise, NS; Spier, AW; Wright, NA, 2002) |
| " The patient was under amiodarone and sotalol therapy for atrial fibrillation, with no obvious QT prolongation prior to ciprofloxacin therapy." | 3.75 | Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy. ( Arnaoutoglou, C; Chrisopoulos, C; Keivanidou, A; Kirpizidis, C; Krommydas, A; Papanikolaou, G; Tsiptses, K, 2009) |
| "Thirteen patients developed syncope and a prolonged QTc interval while taking therapeutic doses of sotalol." | 3.67 | Sotalol, hypokalaemia, syncope, and torsade de pointes. ( Barlow, JB; McKibbin, JK; Millar, RN; Obel, IW; Pocock, WA, 1984) |
| "Arrhythmogenic right ventricular dysplasia is an inherited, progressive condition." | 1.31 | Arrhythmogenic right ventricular dysplasia. An illustrated review highlighting developments in the diagnosis and management of this potentially fatal condition. ( Fisher, NG; Gilbert, TJ, 2000) |
| "Ventricular arrhythmias play an important role in the pathophysiologic aspects of sudden cardiac death." | 1.27 | Identification of patients at high risk for sudden cardiac death. ( Bigger, JT, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (22.73) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Reynolds, MR | 1 |
| Bunch, TJ | 1 |
| Steinberg, BA | 1 |
| Ronk, CJ | 1 |
| Kim, H | 1 |
| Wieloch, M | 1 |
| Lip, GYH | 1 |
| Chatterjee, D | 1 |
| DeLillo, DM | 1 |
| Jesty, SA | 1 |
| Souza, MJ | 1 |
| Conte, G | 1 |
| Sieira, J | 1 |
| Ciconte, G | 1 |
| de Asmundis, C | 1 |
| Chierchia, GB | 1 |
| Baltogiannis, G | 1 |
| Di Giovanni, G | 1 |
| La Meir, M | 1 |
| Wellens, F | 1 |
| Czapla, J | 1 |
| Wauters, K | 1 |
| Levinstein, M | 1 |
| Saitoh, Y | 1 |
| Irfan, G | 1 |
| Julià, J | 1 |
| Pappaert, G | 1 |
| Brugada, P | 1 |
| Ferasin, L | 1 |
| Keivanidou, A | 1 |
| Arnaoutoglou, C | 1 |
| Krommydas, A | 1 |
| Papanikolaou, G | 1 |
| Tsiptses, K | 1 |
| Chrisopoulos, C | 1 |
| Kirpizidis, C | 1 |
| Er, F | 1 |
| Nia, AM | 1 |
| Erdmann, E | 1 |
| Meurs, KM | 1 |
| Spier, AW | 1 |
| Wright, NA | 1 |
| Atkins, CE | 1 |
| DeFrancesco, TC | 1 |
| Gordon, SG | 1 |
| Hamlin, RL | 1 |
| Keene, BW | 1 |
| Miller, MW | 1 |
| Moise, NS | 1 |
| Zakrzewska, A | 1 |
| Makowska, AM | 1 |
| Górnicka, B | 1 |
| Szostek, M | 1 |
| Bar-Andziak, E | 1 |
| Binder, WD | 1 |
| Fifer, MA | 1 |
| King, ME | 1 |
| Stone, JR | 1 |
| Laakso, M | 1 |
| Pentikäinen, PJ | 1 |
| Pyörälä, K | 1 |
| Neuvonen, PJ | 1 |
| McKibbin, JK | 1 |
| Pocock, WA | 1 |
| Barlow, JB | 1 |
| Millar, RN | 1 |
| Obel, IW | 1 |
| Bigger, JT | 1 |
| Antonaccio, MJ | 1 |
| Lessem, JN | 1 |
| Soyka, LF | 1 |
| Kuck, KH | 1 |
| Kunze, KP | 1 |
| Roewer, N | 1 |
| Bleifeld, W | 1 |
| Galatius-Jensen, S | 1 |
| Clemmensen, PM | 1 |
| Pietersen, AH | 1 |
| Nielsen, HV | 1 |
| Makkar, RR | 1 |
| Fromm, BS | 1 |
| Steinman, RT | 1 |
| Meissner, MD | 1 |
| Lehmann, MH | 1 |
| de Meester, A | 1 |
| Chaudron, JM | 1 |
| de Roy, L | 1 |
| Panhuyzen-Goedkoop, NM | 1 |
| Crijns, HJ | 1 |
| Tarantini, G | 1 |
| Menti, L | 1 |
| Angelini, A | 1 |
| Martini, B | 1 |
| Thiene, G | 1 |
| Daliento, L | 1 |
| Fisher, NG | 1 |
| Gilbert, TJ | 1 |
| Kuntz, RE | 1 |
| Ruskin, JN | 1 |
| Weinberger, S | 1 |
| Lorell, BH | 1 |
1 review available for sotalol and Syncope
| Article | Year |
|---|---|
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramid | 1993 |
1 trial available for sotalol and Syncope
| Article | Year |
|---|---|
Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Dog Diseases; Dogs; Drug Therapy, C | 2002 |
20 other studies available for sotalol and Syncope
| Article | Year |
|---|---|
Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Dizziness; Dronedarone; Dyspnea; Electronic Heal | 2023 |
A case of palpitation and pre-syncope.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Sotalol; Sy | 2017 |
Episodic syncope caused by ventricular flutter in a tiger (Panthera tigris).
Topics: Animals; Anti-Arrhythmia Agents; Lidocaine; Male; Panthera; Sotalol; Syncope; Ventricular Flutter | 2013 |
Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Belgium; Brugada Syndr | 2015 |
Recurrent syncope associated with paroxysmal supraventricular tachycardia in a Devon Rex cat diagnosed by implantable loop recorder.
Topics: Animals; Anti-Arrhythmia Agents; Cat Diseases; Cats; Electrocardiography, Ambulatory; Male; Sotalol; | 2009 |
Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents; Atrial Fibrillation; Ciprofloxacin; | 2009 |
[79-year-old patient with paroxysmal artial fibrillation and syncope].
Topics: Aged; Antihypertensive Agents; Atrial Fibrillation; Diagnosis, Differential; Electrocardiography; Hu | 2009 |
[Dramatic symptoms of pheochromocytoma in old woman during antiarrhythmic therapy with sotalol: case report].
Topics: Adrenal Gland Neoplasms; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Diagnosis, Differential; F | 2003 |
Case records of the Massachusetts General Hospital. Case 26-2005. A 48-year-old man with sudden loss of consciousness while jogging.
Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Death, Sudden, Cardiac; Diagnosis, Differentia | 2005 |
Prolongation of the Q-T interval caused by sotalol--possible association with ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Atenolol; Electrocardiography; Heart Ventricles; Humans; Kinetics; Male | 1981 |
Sotalol, hypokalaemia, syncope, and torsade de pointes.
Topics: Adult; Aged; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; Female; H | 1984 |
Identification of patients at high risk for sudden cardiac death.
Topics: Anilides; Arrhythmias, Cardiac; Death, Sudden; Encainide; Heart; Heart Ventricles; Humans; Prognosis | 1984 |
Sotalol, hypokalaemia, syncope, and torsade de pointes.
Topics: Aged; Humans; Hypokalemia; Sotalol; Syncope; Tachycardia | 1984 |
Sotalol-induced torsade de pointes.
Topics: Adult; Electrocardiography; Female; Humans; Sotalol; Syncope; Tachycardia | 1984 |
[Diagnosis of long QT syndrome with the help of atropine provoked ventricular tachycardia].
Topics: Atropine; Electrocardiography; Female; Humans; Injections, Intravenous; Long QT Syndrome; Middle Age | 1994 |
Usefulness of isoproterenol in the induction of clinical sustained ventricular tachycardia during electrophysiological study.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Pacing, Artificial; E | 1997 |
[Iatrogenic collapse; can this be prevented?].
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Disopyramide; Erythro | 1997 |
Life-threatening ventricular arrhythmias associated with giant cell myocarditis (possibly sarcoidosis).
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Middle Ag | 2000 |
Arrhythmogenic right ventricular dysplasia. An illustrated review highlighting developments in the diagnosis and management of this potentially fatal condition.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventric | 2000 |
The advantage of d-sotalol over dl-sotalol in a patient with ventricular arrhythmias and comorbid bronchospasm.
Topics: Bronchial Spasm; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Sotalol; Stereoisomerism; Sy | 1992 |